Benjamin F. Edwards & Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $31K | Buy |
226
+7
| +3% | +$960 | ﹤0.01% | 1444 |
|
|
2024
Q1 | $30K | Sell |
219
-28
| -11% | -$3.84K | ﹤0.01% | 1424 |
|
|
2023
Q4 | $33K | Buy |
+247
| New | +$33K | ﹤0.01% | 1364 |
|
|
2023
Q1 | – | Sell |
-2,646
| Closed | -$316K | – | 1867 |
|
|
2022
Q4 | $316K | Buy |
+2,646
| New | +$316K | 0.01% | 588 |
|
|
2022
Q3 | – | Sell |
-46
| Closed | -$4K | – | 1877 |
|
|
2022
Q2 | $4K | Buy |
+46
| New | +$4K | ﹤0.01% | 1592 |
|
|
2021
Q4 | – | Sell |
-100
| Closed | -$10K | – | 1746 |
|
|
2021
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 1379 |
|
|
2021
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 1382 |
|
|
2021
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 1362 |
|
|
2020
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 1279 |
|
|
2020
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 1278 |
|
|
2020
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 1243 |
|
|
2020
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 1300 |
|
|
2019
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 1407 |
|
|
2019
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 1442 |
|
|
2019
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 1489 |
|